Pfizer (PFE) Inventory Average (2009 - 2026)

Pfizer (PFE) has 18 years of Inventory Average data on file, last reported at $10.7 billion in Q1 2026.

• Inventory Average for Q1 2026 came in at $10.7 billion, down 1.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.7 billion (down 1.76% YoY), and the FY2025 annual result was $10.8 billion, down 4.73% from the prior year.
• Inventory Average retreated to $10.7 billion in Q1 2026 per PFE's latest filing, from $11.1 billion in the prior quarter.
• Over five years, Inventory Average peaked at $11.6 billion in Q3 2024 and troughed at $9.2 billion in Q4 2022.
• A 5-year average of $10.5 billion and a median of $10.5 billion in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2023: Inventory Average increased 17.15% in 2022, then slipped 2.85% in 2023.
• A 5-year view of Inventory Average shows it stood at $9.2 billion in 2022, then increased by 10.27% to $10.2 billion in 2023, then increased by 10.69% to $11.3 billion in 2024, then declined by 1.99% to $11.1 billion in 2025, then dropped by 3.62% to $10.7 billion in 2026.
• Business Quant data shows PFE's Inventory Average at $10.7 billion in Q1 2026, $11.1 billion in Q4 2025, and $11.6 billion in Q3 2025.